Icotinib plus gemcitabine for metastatic pancreatic cancer: A case report

doi:10.3748/wjg.v21.i11.3441

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5543)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

377

WORD

204

HTML

2558

Figures (1-4)

413

Sum=3552

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

911

Download

1080

Sum=1991

Mar 21, 2015 (publication date) through Mar 7, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Mar 21, 2015; 21(11): 3441-3446
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3441

Full Size Figure Download Figure

Figure 1 Contrast-enhanced magnetic resonance imaging of the pancreas. A: Before treatment, a mass was observed (arrow) in the head of pancreas; B: Marked shrinkage of the mass was seen after two treatment cycles; C: Mass size remained stable after four treatment cycles.

Citation: Zhao J, Shen H, Hu HG, Huang JJ. Icotinib plus gemcitabine for metastatic pancreatic cancer: A case report. World J Gastroenterol 2015; 21(11): 3441-3446
URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3441.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3441